Nektar Therapeutics
NKTR
$75.28
$3.074.25%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
7/21/2025
-
MarketBeat
3/17/2026
-
Globe Newswire
3/17/2026
-
Globe Newswire
3/17/2026
-
Business Wire
3/17/2026
-
Simply Wall St
3/17/2026
-
Globe Newswire
3/17/2026
-
Globe Newswire
3/17/2026
-
PR Newswire
3/17/2026
-
MarketBeat
3/17/2026
-
Globe Newswire
3/16/2026
-
Globe Newswire
3/16/2026
-
PR Newswire
3/16/2026
-
MarketBeat
3/16/2026
-
Business Wire
3/16/2026
-
Zacks Investment Research
3/16/2026
-
Zacks Investment Research
3/16/2026
-
PR Newswire
3/15/2026
-
PR Newswire
3/15/2026
-
MarketBeat
3/15/2026
-
Simply Wall St
3/14/2026
-
Globe Newswire
3/14/2026
-
MarketBeat
3/14/2026
-
TipRanks Financial Blog
3/13/2026
-
Simply Wall St
6/30/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, March 13, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
415 482 5300
Address
455 Mission Bay Boulevard South
San Francisco, CA 94158
San Francisco, CA 94158
Country
Year Founded
Business Description
Sector
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops...
more